ReviewBMJ (Clinical research ed.)2004
Detection, verification, and quantification of adverse drug reactions.
Review in BMJ (Clinical research ed.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
77 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Impact of literature reports on drug safety signals.Wiener klinische Wochenschrift · 2021Pooled it
- Intensive Monitoring Studies for Assessing Medicines: A Systematic Review.Frontiers in medicine · 2019Pooled it
- Impact of safety-related regulatory action on clinical practice: a systematic review.Drug safety · 2012Pooled it
- Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.PLoS medicine · 2011Pooled it
- Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance.Drug safety · 2007Pooled it
- Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.European journal of clinical pharmacology · 2013Trial
- Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System.PloS one · 2026Article
- Article
- Educational intervention impact assessment on pharmacovigilance knowledge, attitude and practice among hospital pharmacy practitioners in Dubai.Journal of pharmaceutical policy and practice · 2025Article
- Evaluation of the knowledge of and attitudes towards pharmacovigilance among healthcare students in China: a cross-sectional study.BMC medical education · 2024Article
- An Exploratory Bibliometric Analysis of African Pharmacovigilance Research Output Using SCOPUS.Cureus · 2024Review
- Natural language processing for automated triage and prioritization of individual case safety reports for case-by-case assessment.Frontiers in drug safety and regulation · 2023Article
- Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study.JMIR formative research · 2022Article
- Is Omalizumab Related to Ear and Labyrinth Disorders? A Disproportionality Analysis Based on a Global Pharmacovigilance Database.Diagnostics (Basel, Switzerland) · 2022Article
- Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center.Drugs - real world outcomes · 2022Article
- Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancers.Scientific reports · 2022Article
- Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions.Clinical pharmacology and therapeutics · 2021Article
- Survery of healthcare professionals to assess the awareness, knowledge and self-reported behavior regarding recent fluoroquinolones safety issues.Medicine and pharmacy reports · 2021Article
- Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation.Drug safety · 2021Article
- Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems.Therapeutics and clinical risk management · 2021Article
17 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.